Too much medicine

Schematic diagram: Too much medicine

“Too much medicine” is the idea, and the name of an organized effort, holding that more diagnosis, testing and treatment is not always better and can itself become a cause of harm; it is closely tied to overdiagnosis, the detection of “disease” that would never have hurt the person found to have it. The phrase reframes a familiar worry. Rather than asking only whether patients are getting enough care, it asks whether populations are now getting too much: too many labels, too many tests and too many treatments whose harms, for milder cases, outweigh their benefits.

This is an independent reference explaining that movement and its central claim. It is not medical advice, and “too much medicine” is a statement about health systems and thresholds, not an instruction to any individual about their own tests or medications.

What “too much medicine” actually means

At its core the phrase makes a simple, uncomfortable point: medicine is powerful, and powerful things can be overused. Overuse takes several forms that reinforce one another. Diagnostic thresholds are lowered so that more healthy people qualify as sick. Sensitive tests and scans detect ever-smaller abnormalities, many harmless. Risk factors such as blood pressure, blood sugar and bone density are treated as diseases in their own right. And treatments are applied to mild or borderline cases where the benefit is small and the side effects are not. Each step can be defended on its own; together they push more and more people into patienthood. The “too much medicine” argument is that somewhere along this path the added care stops helping and starts harming, and that medicine has, in places, crossed that line.

The BMJ Too Much Medicine initiative

The best-known banner for this work is the Too Much Medicine initiative run by The BMJ (the British Medical Journal). It gathers research, analysis and debate specifically on overdiagnosis, overtreatment and the widening of disease definitions, giving clinicians and researchers a place to document where medical care may be doing more harm than good. The initiative is deliberately sober in tone: its purpose is not to attack medicine but to turn a critical, evidence-based eye on its excesses, examining particular conditions and asking whether expanding their definitions has helped or harmed the people newly caught by them. By putting the question inside a leading medical journal, it made “too much medicine” a mainstream professional concern rather than a fringe complaint.

A wider movement against overdiagnosis

The BMJ initiative is one part of a broader current running through medicine over the past two decades.

  • The Preventing Overdiagnosis conference brings together researchers and clinicians internationally to study how overdiagnosis happens and how to reduce it.
  • Choosing Wisely, a campaign begun in the United States and adopted in many countries, asks medical specialty societies to name common tests and treatments that offer little benefit, and encourages clinicians and patients to question them.
  • The PLoS Medicine collection on disease mongering helped establish the academic study of how ordinary life and mere risk get reframed as illness.
  • Writers and clinicians including H. Gilbert Welch, whose book Overdiagnosed brought the concept to a general audience, and figures such as Iona Heath, Ray Moynihan and Alan Cassels, authors of Selling Sickness, have made the case in books and journals alike.

What unites these threads is not hostility to medicine but a shared insistence that its benefits and harms be weighed together, and that “more” not be assumed to mean “better.”

How much is too much?

The everyday phrasing of this question, “how much is too much medicine”, has both a literal and a systemic meaning, and it helps to keep them apart. Literally, any single drug taken beyond its safe range can harm the body, and some common medicines strain specific organs: excess acetaminophen (paracetamol) is a leading cause of liver injury, and certain drug classes can damage the kidneys over time. Those are questions for a pharmacist or doctor and depend entirely on the drug and the person. The systemic meaning is the one this movement addresses: the point at which adding more diagnosis and treatment across a whole population stops improving health and starts subtracting from it. Both meanings share the same shape, a curve that rises, peaks and then turns downward, so that beyond the peak, more medicine yields not more health but more harm.

Not less care, but the right care

It is important to be clear about what the movement does not claim. It does not say that medicine is bad, that diseases are invented, or that people should avoid doctors or refuse treatment. Undertreatment is real and dangerous, and many people still receive too little care, not too much. The argument is narrower and more precise: that the amount of appropriate medicine is finite, that it is possible to overshoot it, and that overshooting has real costs, in side effects, in anxiety, in cascades of further testing, and in turning healthy people into patients. Seen this way, “too much medicine” is not a slogan against healthcare but a plea for proportion, for matching the intensity of diagnosis and treatment to the actual threat a person faces. Its goal is not less medicine for its own sake, but the right medicine, given to the people who will genuinely benefit.

Where to go next